News
4 Stocks Lift Dividends As Much as 33% As Banks Pass Stress Tests
Several prominent stock market players just declared, or announced intentions to declare, large dividend increases. This is particularly true among some of the United States' biggest banks. Many
Medicines for Poland gibt bekannt: Ohne pharmazeutische Fabriken wird Europa jeden Krieg verlieren
BRÜSSEL, July 08, 2025 (GLOBE NEWSWIRE) -- Die Notwendigkeit, einen Fonds aus dem EU-Haushalt einzurichten, um die Produktion kritischer Arzneimittel in Europa zu unterstützen, ist eine
EBC Financial Group feiert mehrere Auszeichnungen im Jahr 2025
EBC ist sowohl von World Finance als auch von Online Money Awards für seine Führungsrolle im CFD-Trading, die Leistungsfähigkeit seiner Plattform und seine vertrauenswürdigen, traderorientierten
Wolfspeed Stock: Shares Soar After Bankruptcy Filing
Semiconductor manufacturer Wolfspeed's stock paradoxically surged over 150% after filing for Chapter 11 bankruptcy protection, as investors responded positively to the company's strategic financial
Biotech Catalyst Alert: NKTR, CDTX & WGS Rallying With Big Gains
The biopharmaceuticals space is notorious for sudden, sharp rallies, and for precipitous sell-offs as well. The industry is crowded with names, many of which are tiny firms working toward
Moderna Aktie: Grippe-Impfstoff triumphiert in Studie
Durchbruch für die Moderna-Pipeline: Der mRNA-Grippe-Impfstoff mRNA-1010 schneidet in der entscheidenden Phase-3-Studie deutlich besser…
Der Beitrag Moderna Aktie: Grippe-Impfstoff triumphiert in
3 Summer Short-Squeeze Candidates With Catalysts for Covering
Short squeezes, a market condition where quickly exiting short sellers cause stock prices to rise sharply, can lead to substantial gains for traders and investors. The problem is that a high short
AutoNation: Growth Engines Make It an Undervalued Stock
AutoNation’s (NYSE: AN) stock recently touched a new 52-week high, a milestone that often signals a company’s value is fully recognized by the market. For many investors, a peak price might
3 Biotech Stocks to Watch: Iovance, Neurocrine & Viking
With the notable exceptions of Novo Nordisk A/S (NYSE: NVO) and Eli Lilly & Co. (NYSE: LLY), biotechnology stocks had a rough time attracting investment capital in 2024. Small- and mid-cap biotech
Moderna Aktie: Wichtige Punkte
Moderna schockt mit einer radikalen Neuausrichtung – und die Märkte reagieren verhalten. Der Biotech-Pionier…
Der Beitrag Moderna Aktie: Wichtige Punkte erschien zuerst auf kapitalmarktexperten.de.
Nektar Jumps 157% on Drug Trial Data—Can It Go Even Higher?
On June 24, Nektar Therapeutics (NASDAQ: NKTR) stock exploded nearly 157% following news that Rezpeg, the company’s experimental treatment for atopic dermatitis (eczema), successfully met its
3 Notable Stocks Just Split: Which One Could Be The Big Winner?
Jared Woodard, Head of the Research Investment Committee at Bank of America Securities, argues that stock splits can be very positive for shares. Woodard’s research found that in the 52 weeks
3 Hot Trades for Insiders, But Are They Good Buys for Investors?
Insider activity increased in stocks such as Hudson Pacific Properties (NYSE: HPP), NeoGenomics (NASDAQ: NEO), and Carvana (NYSE: CVNA), signaling opportunities for traders and investors alike
Rio Tinto Aktie: Milliarden-Sprint nach Australien
Rio Tinto startet mit Partner Hancock Prospecting ein monumentales Eisenerz-Vorhaben in Australien. 1,6 Milliarden…
Der Beitrag Rio Tinto Aktie: Milliarden-Sprint nach Australien erschien zuerst auf
IMBRUVICA® (ibrutinib) erhält positiven CHMP-Bescheid für die Behandlung von Patienten mit zuvor unbehandeltem Mantelzell-Lymphom (MCL), die für eine autologe Stammzelltransplantation in Frage kommen
Die Therapie, die erst noch durch die Europäische Kommission abschließend genehmigt werden muss, bietet das Potenzial, einen neuen Versorgungsstandard für geeignete MCL-Patienten zu schaffen.1,2
Dan Ives Just Unveiled His AI ETF—Does It Live Up to the Hype?
A new AI-focused ETF just hit the market with backing from one of the most well-known tech analysts on Wall Street: Dan Ives.
Ives is the Managing Director, Global Head of Technology Research at
United States Steel Stock: Japan Clinches Deal With Golden Strings
After 18 months of contentious negotiations, Nippon Steel has completed its $14.9 billion acquisition of United States Steel, paying $55 per share. However, what began as a strategic expansion has
3 Tech Stocks You Can't Miss in This Market Cycle
There comes a point in each stock market cycle when most investors begin to focus on a specific type of company to target. In the past, these companies might have been the tried-and-tested
3 Stocks With Major Buyback Power: AI & Auto in Focus
Buyback capacity is moving up in a very big way for three stocks. Two tech stocks hoping to leverage and profit from AI are indicating that management has significant confidence in generating
Iran Conflict Fuels Fertilizer Stocks’ Bullish Setup
As conflict breaks out in the Middle East between Israel and Iran, markets have begun to react as anyone would normally expect. Stock indexes, such as the NASDAQ-100 and S&P 500, have leveled off
Indirekter Behandlungsvergleich deutet auf signifikanten Wirksamkeitsvorteil von IMBRUVICA® (ibrutinib) plus venetoclax gegenüber acalabrutinib plus venetoclax in der Erstlinienbehandlung von Patienten mit chronischer lymphatischer Leukämie hin
Studienübergreifende Ergebnisse zeigen einen signifikanten klinischen Nutzen einer Erstlinienbehandlung mit ibrutinib plus venetoclax über einen festgelegten Zeitraum, mit einer verbesserten
United States Steel Stock: Nippon Deal Faces Crucial Deadline
The potential $14.1 billion acquisition of United States Steel by Japanese conglomerate Nippon Steel has evolved into a high-stakes economic drama approaching a critical deadline. After months of
Gold and Commodities: Is the Bull Case Gaining Momentum?
The S&P 500 is finally approaching new all-time highs after a turbulent spring, driven by strong earnings and easing trade war tensions. And it’s not just domestic stocks rebounding; European
Denodo erhält Snowflake-Zertifizierung für Finanzdienstleistungen und stärkt damit die Unterstützung von Brancheninnovationen und Daten-Governance
Stark regulierte Finanzunternehmen können sich auf eine sichere, skalierbare und regelkonforme Datenintegration für strategische Datenanforderungen verlassen
PALO ALTO, Kalifornien, June 12, 2025
The Other AI Chipmaker: Why Marvell's Dip Is a Buy
In the race to power artificial intelligence (AI), some of the most essential players operate just outside the spotlight. Marvell Technology (NASDAQ:




